Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease‐Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A... by Yuxiang Li, Bin Huang, Sandra Andorf, Xiaomeng Yue, Daniel J. Lovell, Hermine I. Brunner

Get full text

Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers by Ellen M. Cody, Alyssa Sproles, James Rose, Bin Huang, Prasad Devarajan, Hermine I. Brunner, Sherry Thornton

Get full text

Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis by Kim Nguyen, Shima Yasin, Ndate Fall, Alexei A. Grom, Hermine I. Brunner, Christopher Towe, Grant S. Schulert

Get full text

Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale by Ekemini A. Ogbu, Anna Carmela P. Sagcal‐Gironella, B. Anne Eberhard, Jennifer M. Huggins, Marisa S. Klein‐Gitelman, Karen Onel, Chen Chen, Bin Huang, Hermine I. Brunner

Get full text

New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development by Roberto De Lisa, Fernando de Andres-Trelles, Fernando de Andres-Trelles, Ralph Bax, Sara Galluzzo, Sara Galluzzo, Brian Alward, Brian Alward, Andrew Thomson, Dominik Karres, Hermine I. Brunner, Nicolino Ruperto, Nicolino Ruperto, Gunter F. Egger

Get full text

Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticula... by Hermine I Brunner, Chen Chen, Yin Zhang, Bin Huang, Timothy Beukelman, Tingting Qiu, Michael Seid, Dan Lovell, Esi M Morgan, Michelle Adams, Anne Kocsis, Melanie Kohlheim, Jeff Guo, Stephanie Gray, Jinzhong Liu, Alivia Neace, Siva Sivaganisan, Stacey Woeste, Xiaomeng Yue, Janet Zahner

Get full text